Draft:Algenesis Labs

• Comment: See further discussion about changes made and source reliability at the author's talk page. LittlePuppers (talk) 16:39, 30 July 2026 (UTC)

• Comment: Note: this draft been deleted twice in the past (G11). LittlePuppers (talk) 16:39, 30 July 2026 (UTC)

• Comment: This draft has several in-depth sources, and its tone is better than many drafts about corporations. However, neither of these in and of themselves convey notability. For that, the subject needs significant coverage in reliable sources that are independent of the topic. Looking at the sources, a few are trivial or routine coverage; these are not inherently poor sources, but do not demonstrate notability. Most seem to satisfy the "reliable" guideline. But determining independence is where interpretation becomes difficult. Looking through the sources with significant coverage, it seems that Algenesis had a hand in writing the vast majority of them. It is difficult to say how heavy of a hand. Some are largely interviews. Some the company has, seemingly, a lesser say in (and indeed, it is to a journalist's credit, not detriment, when he seeks comment from the subject of his writing). But most seem the sort of article that gets written when a company's marketing team suggests they be written; and the pattern is concerning enough that I feel a need to decline this draft in its current state. LittlePuppers (talk) 02:21, 30 July 2026 (UTC)

• Comment: Restored by request, however there are still issues here. I've already removed several claims backed by press releases (not WP:RS), as well as non-notable awards. The bolded in-line lists are reminiscent of LLM writing and should be converted to prose. I'm still on the fence about this topic but if it can be proven neutral and factual, a reviewer may approve it. If published, future edits should follow WP:COIREQ. ASUKITE 17:57, 28 July 2026 (UTC)

---

Algenesis Labs (legally Algenesis Corporation) is an American materials science company based in San Diego, California. Founded by scientists from the University of California, San Diego (UCSD), the company develops bio-based, biodegradable polyurethane materials marketed under the names Soleic and Bio-Iso.

History

Algenesis was founded in 2016 by UCSD professors Stephen Mayfield, Robert "Skip" Pomeroy, and Michael Burkart, originating from academic research into algae-based biofuels and polymers at the California Center for Algae Biotechnology. Since 2018, the company and its academic partners have received research funding from the National Science Foundation and the U.S. Department of Energy, including SBIR/STTR awards supporting algae-based polyurethane development; and a contract to develop commercial scale manufacturing plans under the U.S. Department of Defense's Distributed Bioindustrial Manufacturing Program. In 2021, it transitioned to commercial production, focusing on the footwear and fashion industries.

Technology

Algenesis's core technology involves bio-based polyurethane (PU) and thermoplastic polyurethane (TPU), marketed as Soleic, along with a biogenic isocyanate component marketed as Bio-Iso. Soleic materials, unlike petroleum-based plastics, are intended to be consumed by microorganisms: a 2024 study co-authored by company researchers and published in Scientific Reports indicated that micro-particles of its Soleic TPU-FC1 achieved 76% biodegradation in home compost conditions within 200 days, though the rate of degradation varies with material density and environmental conditions such as soil or marine exposure. In August 2025, Algenesis commissioned a pilot plant for Bio-Iso, developed under a U.S. Department of Energy SBIR award; the process uses plant-derived dicarboxylic acids and non-phosgene flow chemistry, intended to avoid the toxic precursors used in traditional isocyanate manufacturing.

Reception

Algenesis's technology has drawn coverage from independent trade and general-interest media. Chemistry World has reported on the company's diisocyanate technology and its role in industrial biomanufacturing, while Chemical & Engineering News examined its biodegradation claims alongside independent academic perspectives on biodegradable plastics generally. Inverse covered a peer-reviewed study of the company's seawater-biodegradable foam, citing an outside chemist's broader skepticism about the prospects of biodegradable plastics as a category. Urethanes Technology International reported on the company's business strategy, manufacturing partnerships, and biodegradation testing, and Fast Company profiled its early algae-based flip-flop material and its potential to reduce plastic pollution. It has also appeared in broadcast coverage: PBS's Human Footprint featured the company in the episode "Dressed to Kill," on synthetic textile waste, and Business Insider's World Wide Waste included it in a segment titled "Why Most 'Biodegradable' Products Are Probably Fake," which examined biodegradability claims across the footwear industry, including the company's own comparative testing of its shoes.

Partnerships

Algenesis has a supply partnership with P2 Science, in which P2 Science provides algae-derived azelaic acid for the Bio-Iso platform. It has also worked with Ecogenesis Biopolymers on genTPU, a plant-based 3D printing filament.